[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-james-edgemond-sells-21000-sha33019ae674-cb4a-795d-aef0-a581978a681d":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":11,"showTags":12,"source":13,"reactions":14,"selfReactions":15,"logo":16,"sourceId":17,"sourceUserId":18,"asset":19,"tagsCategories":20,"totalComments":21,"lang":22,"unique_views_count":21,"enrichStatus":19,"triageKind":18,"triageImportance":18,"expandEligible":18,"summarizeEligible":18,"eventEligible":18,"eventType":18,"eventAction":18},"james-edgemond-sells-21000-sha33019ae674-cb4a-795d-aef0-a581978a681d","1764802135000","James Edgemond Sells 21,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock","United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CFO James Edgemond sold 21,000 shares of the business's stock in a transaction on Monday, December 1st. The shares were sold at an average price of $479.99, for a total value of $10,079,790.00. Following the completion of the sale, the chief financial officer owned 8,142 shares in the company, valued at approximately $3,908,078.58. The trade was a 72.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.","https://www.marketbeat.com/instant-alerts/james-edgemond-sells-21000-shares-of-united-therapeutics-nasdaquthr-stock-2025-12-02/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","[\"-\"]","[{\"name\":\"-\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/-.png\"}]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Finance\"]","0","EN"]